--- title: "SR-9009 (stenabolic): Dosing & Vendor Prices" description: "SR-9009 (stenabolic): dosing protocols, mechanism & side effects. Compare 1 verified vendor prices." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compounds", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "SR-9009 (stenabolic)" } ] }, { "@context": "https://schema.org", "@type": "Product", "name": "SR-9009 (stenabolic)", "description": "SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next.", "url": "https://www.bodyhackguide.co/compound/sr-9009", "image": "https://www.bodyhackguide.co/og-image.png", "brand": { "@type": "Brand", "name": "Research Compound" }, "offers": { "@type": "AggregateOffer", "lowPrice": "59.99", "highPrice": "79.99", "priceCurrency": "USD", "offerCount": "2", "availability": "https://schema.org/InStock", "offers": [ { "@type": "Offer", "price": "59.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://disguisedalpha.com/product/sr9009capsules/?coupon=reddit", "seller": { "@type": "Organization", "name": "Disguised Alpha", "url": "https://disguisedalpha.com/?coupon=reddit" } }, { "@type": "Offer", "price": "79.99", "priceCurrency": "USD", "availability": "https://schema.org/InStock", "itemCondition": "https://schema.org/NewCondition", "url": "https://disguisedalpha.com/product/sr-9009/?coupon=reddit", "seller": { "@type": "Organization", "name": "Disguised Alpha", "url": "https://disguisedalpha.com/?coupon=reddit" } } ] } }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "SR-9009 (stenabolic)", "description": "SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next.", "lastReviewed": "2026-09-07T04:47:51.079Z", "url": "https://www.bodyhackguide.co/compound/sr-9009", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "SR-9009 (stenabolic)", "alternateName": [ "SR9009", "Stenabolic", "SR-9009", "Rev-erb agonist SR9009" ], "description": "SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next.", "activeIngredient": "SR-9009 (stenabolic)", "administrationRoute": "Intraperitoneal injection (rodent studies), Oral (as sold on the research chemical market)", "mechanismOfAction": "SR-9009 is a synthetic agonist at REV-ERB-alpha (NR1D1) and REV-ERB-beta (NR1D2), heme-binding nuclear receptors that act as transcriptional repressors within the core circadian clock. Agonist binding increases their repressive activity on target promoters, altering the daily expression pattern of clock genes in the hypothalamus and of metabolic genes in liver, skeletal muscle and adipose tissue, with increased energy expenditure in mice (PMID: 22460951). REV-ERB-alpha also regulates skeletal muscle mitochondrial biogenesis and autophagy through the LKB1-AMPK-SIRT1-PGC-1alpha pathway (PMID: 23852339). Target attribution is contested: in hepatocytes and embryonic stem cells genetically lacking both REV-ERB proteins, SR-9009 still altered viability, metabolism and transcription, showing REV-ERB-independent activity (PMID: 31127047).", "dosageForm": "capsule, liquid", "legalStatus": "Not approved for human use — research chemical", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is SR-9009 (stenabolic) used for in research?", "acceptedAnswer": { "@type": "Answer", "text": "SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next." } }, { "@type": "Question", "name": "What forms does SR-9009 (stenabolic) come in?", "acceptedAnswer": { "@type": "Answer", "text": "SR-9009 (stenabolic) is available in capsule, liquid forms." } }, { "@type": "Question", "name": "How much does SR-9009 (stenabolic) cost?", "acceptedAnswer": { "@type": "Answer", "text": "Prices start at $59.99 across 1 verified vendor." } }, { "@type": "Question", "name": "How do I compare SR-9009 (stenabolic) vendors?", "acceptedAnswer": { "@type": "Answer", "text": "Compare prices, payment methods, shipping, and COA scores across 1 vendor." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+ — Enter SiteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fcompound%2Fsr-9009) 100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 1. [Home](/) 2. [Compounds](/compare) 3. SR-9009 (stenabolic) [Where to buy SR-9009 (stenabolic)](/buy/sr-9009) [SR-9009 (stenabolic) coupon codes](/coupons/sr-9009) [SR-9009 (stenabolic) protocol](/protocol/sr-9009) [Alternatives to SR-9009 (stenabolic)](/alternatives-to/sr-9009) [SR-9009 (stenabolic) side effects](/side-effects/sr-9009) 1. [Home](/) 3. [Compounds](/compare) 5. SR-9009 (stenabolic) ![SR-9009 (stenabolic) molecular structure](/assets/peptide-structure-placeholder-DUmZBF_j.png) # SR-9009 (stenabolic) Metabolic Preclinical Download PDF Also known as: SR9009, Stenabolic, SR-9009, Rev-erb agonist SR9009 SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). Half-Life: Not established in humans; no human pharmacokinetic study has been published. In the mouse experiments that produced the metabolic findings the compound was given by intraperitoneal injection rather than orally (PMID: 22460951) Route: Intraperitoneal injection (rodent studies), Oral (as sold on the research chemical market) MW: 437.94 g/mol CAS: 1379686-30-2 Last reviewed: Sep 7, 2026 [ Metabolic Category ](/wiki#cat-metabolic) Preclinical Research Stage OverviewChemical InfoDosing & ProtocolsInteractionsResearchCompare Prices2 Related ## Overview ### Best Price Available ![Disguised Alpha logo](https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) Disguised Alpha $59.99 60 capsules · capsule [Buy Now](https://disguisedalpha.com/product/sr9009capsules/?coupon=reddit) Compare 1 vendor ### At A Glance Mechanism SR-9009 is a synthetic agonist at REV-ERB-alpha (NR1D1) and REV-ERB-beta (NR1D2), heme-binding nuclear receptors that act as transcriptional repressors within the core circadian clock. Agonist binding increases their repressive activity on target promoters, altering the daily exp… Half-Life Not established in humans; no human pharmacokinetic study has been published. In the mouse experiments that produced the metabolic findings the compound was given by intraperitoneal injection rather than orally (PMID: 22460951) Routes Intraperitoneal injection (rodent studies) Oral (as sold on the research chemical market) Potential Benefits Increased energy expenditure and reduced fat mass in diet-induced obese mice, with plasma cholesterol down 47 percent, triglycerides down 12 percent and glucose down 19 percent (PMID: 22460951) Increased exercise capacity in mice after pharmacological activation of Rev-erb-alpha, alongside greater muscle mitochondrial content (PMID: 23852339) Altered the circadian pattern of clock and metabolic gene expression in mouse hypothalamus, liver, muscle and adipose tissue (PMID: 22460951) Reduced weight gain and insulin resistance in mice exposed to constant light in a later rodent study (PMID: 39800061) ### Overview SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next. ### Potential Research Fields Circadian biology Nuclear receptor pharmacology Energy metabolism Sports drug testing ## Chemical Information IUPAC Name Not yet available CAS Number 1379686-30-2 Molecular Formula C20H24ClN3O4S Molecular Mass 437.94 g/mol ![SR-9009 (stenabolic) molecular structure](https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/57394020/PNG) [View on PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/57394020) ## Dosing & Protocols ### Unlock Dosing Protocols Free account gets you: - View beginner, intermediate & advanced protocols - See weight-based dosing calculations - Access cycle length & frequency data [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Research ### Unlock Research Data Free account gets you: - Browse PubMed study summaries - See clinical trial phases & results - Access mechanism of action details [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Interactions ### Contraindications No human data exist, so no evidence-based contraindications can be stated. Mechanism-based caution applies to anyone with a circadian or sleep disorder, since the drug is designed to shift clock gene expression (PMID: 22460951), and the documented REV-ERB-independent cytotoxicity in cell studies is an unresolved safety question (PMID: 31127047). Prohibited at all times in tested human and equine sport (PMID: 38735208). Research Disclaimer This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds. Best Price $59.99 up to $79.99 Best $/mg — Vendors 1 Listings 2 capsule, liquid [Sign in for alerts ](/auth) Form Allcapsuleliquid Sort Price $/mg Vendor Vendor Product Form Qty Price $/mg Coupon ![Disguised Alpha logo](https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) [Disguised Alpha](/vendor/disguised-alpha) [50 ](/vendor-trust-scorecard) 🇺🇸 US 🇪🇺 EU 🇬🇧 UK SR-9009 capsules (60) capsule 60 capsules ● In Stock $59.99 BEST — — [Buy](https://disguisedalpha.com/product/sr9009capsules/?coupon=reddit) ![Disguised Alpha logo](https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) [Disguised Alpha](/vendor/disguised-alpha) [50 ](/vendor-trust-scorecard) 🇺🇸 US 🇪🇺 EU 🇬🇧 UK SR-9009 30 mg/mL liquid 1 vial (30 mg/mL) ● In Stock $79.99 — — [Buy](https://disguisedalpha.com/product/sr-9009/?coupon=reddit) Get SR-9009 (stenabolic) Price Drop Alerts Set a target price and we'll notify you when any vendor drops below it. Current lowest: $59.99 [Sign in to set alerts](/auth) ### Sign in to leave a review Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with SR-9009 (stenabolic). [Sign in](/auth) Current low $59.99 as of Sep 7, 2026 7-day low $59.99 30-day low $59.99 30-day change — baseline building Tracking since Sep 7, 2026 · 2 data points ### Vendors Selling SR-9009 (stenabolic) [ ![Disguised Alpha logo](https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) #### Disguised Alpha 2 listings · from $59.99 ](/vendor/disguised-alpha) How we score these vendors Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. [View Scorecard](/vendors/scorecard) ### Related Compounds [View All](/wiki) [ ### AICAR (acadesine) Metabolic Phase 3 AICAR is a nucleoside analog of adenosine. t½ Intact acadesine was measurable in plasma for only about 2 hours after a short intravenous infusion in four healthy men, with total plasma clearance of 2.2 L/h/kg and negligible protein binding; radiolabeled drug-derived material had an apparent terminal half-life of about one week, reflecting metabolites rather than parent compound (PMID: 8227467) Preclinical View Profile ](/compound/aicar)[ ### Amlexanox Metabolic FDA Approved Amlexanox is an old anti-inflammatory drug with a second life. t½ Not established in published human pharmacokinetic studies for the oral capsule form; a validated plasma assay has been used for preclinical pharmacokinetics in rats (PMID: 34842293) Preclinical View Profile ](/compound/amlexanox)[ ### Berberine Metabolic Preclinical Berberine is an isoquinoline alkaloid — a naturally occurring plant secondary metabolite with a characteristic yellow color — extracted from the roots, rhizomes, stems, and bark of several plant genera including Berberis (barberry, Oregon grape), Coptis (goldthread), Hydrastis (goldenseal), Phellodendron (Amur cork tree), and Tinospora (guduchi). Preclinical View Profile ](/compound/berberine)[ ### Cardarine (GW501516) Metabolic Discontinued Cardarine is the market name for GW501516, a synthetic agonist of the nuclear receptor PPAR-delta developed by GlaxoSmithKline as a treatment for low HDL cholesterol and the lipid problems that travel with metabolic syndrome. t½ Not reported in the published human trials; the phase 1 and phase 2 studies described lipid outcomes over two to twelve weeks of oral dosing without publishing a terminal half-life (PMID: 17110604; PMID: 22814748) Preclinical View Profile ](/compound/cardarine)[ ### Metformin Metabolic Preclinical Metformin is a biguanide-class oral antihyperglycemic medication that has been in continuous clinical use since 1957 (in France under the brand name Glucophage) and is now the most-prescribed diabetes medication worldwide with over 150 million prescriptions annually. Preclinical View Profile ](/compound/metformin)[ ### SLU-PP-915 Metabolic Preclinical SLU-PP-915 is an experimental agonist of the estrogen-related receptors, a family of three orphan nuclear receptors called ERR-alpha, ERR-beta and ERR-gamma that control genes for mitochondrial biogenesis, oxidative phosphorylation, fatty acid oxidation and the Krebs cycle. t½ Not established in humans; in mice it is orally bioavailable and active by both oral and intraperitoneal routes, unlike its predecessor SLU-PP-332 (PMID: 41421047) Preclinical View Profile ](/compound/slu-pp-915) [ View Full Dosage Guide → Protocols, calculator & safety for SR-9009 (stenabolic) ](/guides/dosage/sr-9009) ### Best Price ![Disguised Alpha logo](https://disguisedalpha.com/wp-content/themes/assets/logos/disguised-logo-2x.png) Disguised Alpha $59.99 [Buy Now](https://disguisedalpha.com/product/sr9009capsules/?coupon=reddit) 1 vendors · 2 listings ### Research Score 30 0 PubMed studies ### Quality Indicators Data Completeness 63% Description Mechanism of Action Chemical Data Dosing Protocols Safety Profile PubMed Studies Interactions Vendor Listings ### Quick Facts Half-Life Not established in humans; no human pharmacokinetic study has been published. In the mouse experiments that produced the metabolic findings the compound was given by intraperitoneal injection rather than orally (PMID: 22460951) Molecular Weight 437.94 g/mol Administration Intraperitoneal injection (rodent studies), Oral (as sold on the research chemical market) CAS Number 1379686-30-2 Trial Phase Preclinical 0 [Full Dosage Guide](/guides/dosage/sr-9009)[Calculate Your Dose](/tools/reconstitution) Research Disclaimer This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use. ## Frequently Asked Questions What is SR-9009 (stenabolic) used for in research? SR-9009, sold as stenabolic, is a synthetic agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. It came out of Thomas Burris and Theodore Kamenecka laboratory work at the Scripps Research Institute and was first described in a 2012 Nature paper as a tool for pharmacologically shifting the circadian clock and the metabolism it controls (PMID: 22460951). It was never a pharmaceutical company development candidate, has never entered human trials, and has no approval anywhere. Anti-doping laboratories describe it plainly as a compound that failed to reach FDA approval and whose illegal distribution raised concern (PMID: 38735208). REV-ERB proteins sit inside the core circadian clock and repress the genes that drive the daily cycle of activity and fuel use. Activating them with a drug changes the timing and level of metabolic gene expression in liver, muscle and fat. In the original mouse work this raised energy expenditure, and in diet-induced obese mice it reduced fat mass with drops in plasma cholesterol, triglycerides, free fatty acids and glucose (PMID: 22460951). A separate group showed that REV-ERB-alpha controls mitochondrial biogenesis in oxidative muscle and that pharmacological activation increased exercise capacity in mice (PMID: 23852339). There is a serious problem with the mechanism story. When researchers built mice lacking both REV-ERB-alpha and REV-ERB-beta, SR-9009 still reduced cell viability, rewired cellular metabolism and altered gene transcription in cells that had no target left to act on. The authors concluded that the effects of SR-9009 cannot be used as a stand-in for REV-ERB activity (PMID: 31127047). In other words, some of what the compound does in cells is off-target, and which of the metabolic effects are REV-ERB-dependent is unsettled. There are no human data of any kind. No pharmacokinetics, no safety study, no efficacy trial. In the mouse studies that produced the metabolic results, the compound was given by intraperitoneal injection rather than by mouth (PMID: 22460951), which matters because SR-9009 is sold as an oral liquid and as capsules. It is prohibited in sport. WADA lists Rev-erb-alpha agonists including SR9009 and SR9011 under section S4.4, metabolic modulators, and horse and camel racing authorities have developed detection methods for it (PMID: 38735208; PMID: 42530886). When 44 products marketed online as SARMs were chemically analyzed, SR9009 was one of the unapproved drugs found in products that did not list it on the label (PMID: 29183075). What is sold as stenabolic, in liquid or capsule form, is a research chemical with no pharmacopoeial standard, no established human dose and no published human exposure. Buyers are the first humans on record taking it, and there is no monitoring of what happens next. What forms does SR-9009 (stenabolic) come in? SR-9009 (stenabolic) is available in capsule, liquid forms. How much does SR-9009 (stenabolic) cost? Prices start at $59.99 across 1 verified vendor. How do I compare SR-9009 (stenabolic) vendors? Compare prices, payment methods, shipping, and COA scores across 1 vendor. ## Research Tools [ ### Peptide Calculator Reconstitution & syringe units ](/tools/reconstitution)[ ### Reconstitution Guide How to mix, step by step ](/guides/how-to-reconstitute-peptides)[ ### Nasal Spray Calc mL per actuation ](/tools/intranasal)[ ### Half-Life Visualizer Decay curves ](/tools/halflife) ## Related Compounds [View All](/wiki) [ ### AICAR (acadesine) Metabolic Phase 3 AICAR is a nucleoside analog of adenosine. t½ Intact acadesine was measurable in plasma for only about 2 hours after a short intravenous infusion in four healthy men, with total plasma clearance of 2.2 L/h/kg and negligible protein binding; radiolabeled drug-derived material had an apparent terminal half-life of about one week, reflecting metabolites rather than parent compound (PMID: 8227467) Preclinical View Profile ](/compound/aicar)[ ### Amlexanox Metabolic FDA Approved Amlexanox is an old anti-inflammatory drug with a second life. t½ Not established in published human pharmacokinetic studies for the oral capsule form; a validated plasma assay has been used for preclinical pharmacokinetics in rats (PMID: 34842293) Preclinical View Profile ](/compound/amlexanox)[ ### Berberine Metabolic Preclinical Berberine is an isoquinoline alkaloid — a naturally occurring plant secondary metabolite with a characteristic yellow color — extracted from the roots, rhizomes, stems, and bark of several plant genera including Berberis (barberry, Oregon grape), Coptis (goldthread), Hydrastis (goldenseal), Phellodendron (Amur cork tree), and Tinospora (guduchi). Preclinical View Profile ](/compound/berberine)[ ### Cardarine (GW501516) Metabolic Discontinued Cardarine is the market name for GW501516, a synthetic agonist of the nuclear receptor PPAR-delta developed by GlaxoSmithKline as a treatment for low HDL cholesterol and the lipid problems that travel with metabolic syndrome. t½ Not reported in the published human trials; the phase 1 and phase 2 studies described lipid outcomes over two to twelve weeks of oral dosing without publishing a terminal half-life (PMID: 17110604; PMID: 22814748) Preclinical View Profile ](/compound/cardarine)[ ### Metformin Metabolic Preclinical Metformin is a biguanide-class oral antihyperglycemic medication that has been in continuous clinical use since 1957 (in France under the brand name Glucophage) and is now the most-prescribed diabetes medication worldwide with over 150 million prescriptions annually. Preclinical View Profile ](/compound/metformin)[ ### SLU-PP-915 Metabolic Preclinical SLU-PP-915 is an experimental agonist of the estrogen-related receptors, a family of three orphan nuclear receptors called ERR-alpha, ERR-beta and ERR-gamma that control genes for mitochondrial biogenesis, oxidative phosphorylation, fatty acid oxidation and the Krebs cycle. t½ Not established in humans; in mice it is orally bioavailable and active by both oral and intraperitoneal routes, unlike its predecessor SLU-PP-332 (PMID: 41421047) Preclinical View Profile ](/compound/slu-pp-915) Free 2026 Peptide Cheat Sheet — 50 pages, PDF Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one. [Download Free](/guides/peptide-cheat-sheet-download?utm_source=compound-sr-9009) ### Need bloodwork before starting? Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount. [Order Bloodwork](https://anabolicinsights.ai/?ref=nwm2zjb) ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Dosage calculator](/tools/dosage) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Get BHG verified](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) hi 👋